Emitino 8mg (Ondansetron) in Kenya: Product Description

Emitino 8mg (Ondansetron) in Kenya: Product Description

KSh 1,578.00

Emitino 8mg contains ondansetron, a 5-HT3 receptor antagonist used to prevent and treat:

  • Chemotherapy-induced nausea/vomiting (CINV) (high/medium emetogenic chemo).
  • Radiotherapy-induced nausea/vomiting.
  • Post-operative nausea/vomiting (PONV) after surgery.
  • Severe morning sickness (off-label, under strict supervision).

It works by blocking serotonin receptors in the gut and CNS, reducing vomiting signals. In Kenya, Emitino is a critical supportive care drug in oncology and surgical wards, available in hospitals and pharmacies.

Emitino 8mg (Ondansetron) in Kenya: Product Description

KSh 1,578.00

Add to cart
Buy Now

Product Overview

Emitino 8mg contains ondansetron, a 5-HT3 receptor antagonist used to prevent and treat:

  • Chemotherapy-induced nausea/vomiting (CINV) (high/medium emetogenic chemo).
  • Radiotherapy-induced nausea/vomiting.
  • Post-operative nausea/vomiting (PONV) after surgery.
  • Severe morning sickness (off-label, under strict supervision).

It works by blocking serotonin receptors in the gut and CNS, reducing vomiting signals. In Kenya, Emitino is a critical supportive care drug in oncology and surgical wards, available in hospitals and pharmacies.

Key Benefits:

  • Rapid onset (30 mins IV/oral).
  • Minimal sedation vs. older antiemetics (e.g., metoclopramide).
  • First-line for CINV per Kenya National Cancer Treatment Guidelines.

Frequently Asked Questions (FAQs)

  1. What is Emitino 8mg used for?

    • Primary: Nausea/vomiting from chemotherapy, radiation, or surgery.
    • Off-label: Severe hyperemesis gravidarum (pregnancy-related vomiting).
  2. Is Emitino available in Kenya?

    • Yes, stocked in:
      • Oncology centers: Nairobi Hospital, Texas Cancer Center, MP Shah Hospital.
      • Major pharmacies: Goodlife, Medsafes, Cintas Pharma.
      • Government hospitals: Kenyatta National Hospital (KNH), Moi Teaching & Referral Hospital.
    • Cost: ~KES 800–1,500 for 10 tablets; IV vials ~KES 2,000–3,000.
  3. Can I use it for motion sickness or general nausea?

    • No. Emitino is reserved for severe cases (e.g., chemo). Use meclizine or dimenhydrinate for motion sickness.
  4. What are the side effects?

    • Common: Headache, constipation, dizziness.
    • Serious (seek help):
      • QT prolongation (irregular heartbeat – avoid if heart conditions).
      • Serotonin syndrome (if combined with SSRIs/SNRIs).
      • Severe allergic reaction (swelling, breathing trouble).
  5. Is it safe during pregnancy?

    • Category B (animal studies show no risk; human data limited). Use only if benefits outweigh risks (e.g., hyperemesis).

How to Use Emitino 8mg

  • Dosage (Adults):

    • CINV:
      • Oral: 8mg 30 mins before chemo, then 8mg every 8 hours for 1–2 days.
      • IV: 8mg slow infusion over 15 mins pre-chemo.
    • PONV: 16mg 1 hour before surgery.
    • Max Daily Dose: 24mg (oral), 32mg (IV).
  • Administration:

    • Oral: Swallow whole with water. Can be taken with/without food.
    • IV: Only by healthcare professionals (slow infusion to prevent arrhythmias).
  • Missed Dose:

    • Take if remembered soon. Skip if near next dose. Do not double.
  • Critical Precautions:

    • Heart Conditions: Avoid if history of QT prolongation or heart failure.
    • Liver Impairment: Max 8mg/day (reduced clearance).
    • Drug Interactions: Avoid apomorphine, tramadol, SSRIs (e.g., fluoxetine).

Composition

  • Active Ingredient: Ondansetron Hydrochloride Dihydrate (8mg per tablet/vial).
  • Inactive Ingredients (Tablets): Lactose, microcrystalline cellulose, magnesium stearate.
  • IV Solution: Sodium chloride, citric acid, water for injection.
  • Packaging:
    • Tablets: 10s blister pack.
    • IV: 2ml/4ml vials (4mg/ml or 8mg/ml).

Conclusion

Emitino 8mg is a lifesaving antiemetic in Kenya’s cancer and surgical care, offering targeted relief from debilitating nausea/vomiting. Its efficacy in CINV makes it indispensable for chemotherapy patients, but cardiac safety must be prioritized (ECG monitoring for high-risk patients). For accessibility, generics (e.g., Ondem, Zofran) are equally effective and cheaper.

Access & Support in Kenya:

  1. NHIF Coverage:
    • Fully covered under “Supa Cover” for cancer patients (chemo-related nausea).
    • Submit oncologist’s prescription + chemo records.
  2. Cost-Saving Tips:
    • Generics: Ask for Ondansetron 8mg (KES 400–800 for 10 tabs vs. Emitino’s KES 800–1,500).
    • Hospitals: KNH and Moi Referral provide free Emitino to admitted chemo patients.
  3. Patient Support:
    • Faraja Cancer Support: Offers free antiemetics to low-income patients.
    • Kenya Hospices and Palliative Care Association (KEHPCA): Home-based nausea management.

Disclaimer: Not medical advice. Use only under medical supervision

Reviews

There are no reviews yet.

Be the first to review “Emitino 8mg (Ondansetron) in Kenya: Product Description”

Your email address will not be published. Required fields are marked *

Top